The immune response against six synthetic peptides corresponding to various segments of the B subunit of cholera toxin was evaluated. CoWugates in which the peptides were covalently linked to tetanus toxoid served for immunization of rabbits. As previously reported, four of these conjugates elicited antibodies cross-reactive with intact cholera toxin. We report here that antisera against two of these synthetic peptides inhibit the entire spectrum of activities of the intact cholera toxin. This is manifested both on the biochemical level (adenylate cyclase induction) and on the biological effect (intestinal fluid secretion). These results indicate that these peptides may serve as suitable candidates for preparation of a synthetic anticholera vaccine.
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Immunization with synthetic peptides may lead to antibodies capable of cross-reacting with the native protein containing the sequences of those peptides in its structure. This has been reported for hen egg-white lysozyme (1) , for the coat protein of bacteriophage MS-2 (2, 3), for influenza hemagglutinin (4) , and for diphtheria toxin (5), as well as for a number of additional systems, as reviewed elsewhere (6) . Recently, we reported the synthesis of several peptides (CTP1-CTP6) corresponding to various segments of the B subunit of cholera toxin (7) . Some of the antibodies raised in rabbits against conjugates of these peptides and tetanus toxoid reacted to different extents with the intact B subunit and with whole native cholera toxin. The antibodies against peptide CTP3 gave the highest cross-reaction with the native toxin. Furthermore, this was the only peptide that cross-reacted with antibodies raised against the B subunit or the whole toxin. The antiserum against CTP3 peptide significantly inhibited the biological action of cholera toxin, as observed by skin vascular permeability and by fluid accumulation in ligated small intestinal loops of rabbits (7) .
The pathogenesis of cholera disease is characterized by a profuse diarrhea that leads to severe dehydration and hypovolemic shock. This has been believed to be due to disturbance of the ion-transport function of the small intestine as a result of increased production of cAMP in epithelial cells. The latter occurs in response to cholera toxin, which activates the adenylate cyclase in the cell membrane (8) . In view of this, we have evaluated the capacity of antisera against synthetic peptides CTP1-CTP6 to inhibit cholera toxin-induced adenylate cyclase activity.
MATERIALS AND METHODS
Cholera toxin was purchased from Schwarz/Mann. Tetanus toxoid was purchased from Rafa Laboratories (Jerusalem) and purified as a 15-30% saturation cut on (NH4)2SO4 precipitation and then by column chromatography on Sephadex G-100. Human parathyroid hormone (1-34) was a gift from Revlon Health Care Group (Tuckahoe, NY). Isoproterenol was from Sigma. Peptides were synthesized according to the Merrifield solid-phase technique (9) , conjugated to tetanus toxoid (Mr, 150,000) and used for immunization of rabbits as described (7) .
Radioimmunoassay. Solid-phase radioimmunoassay on peptide-coated microtiter plates precoated with 0.2% glutaraldehyde was carried out as described (7).
cAMP Assay. Kidney cells of White Rock chickens, 4-7 weeks old, were used. Dispersed cells were prepared by incubation of kidney slices for 30 min in Eagle's solution containing 20 mM Hepes, collagenase (2 mg/ml, type IV; Sigma) and byaluronidase (1.2 mg/ml, type I-S; Sigma). At the end of the incubation period, the tissue was broken mechanically by forcing it through a 10-ml pipette; the suspension was then filtered through nylon netting and centrifuged for 10 min at 120 x g. The supernatant was discarded and the pellet was suspended in Eagle's solution containing 20 mM Hepes and 2% bovine serum albumin. The cells were allowed to settle by gravitation for 10 min, and the contaminating erythrocytes were siphoned off. Adenylate cyclase was activated by incubation of 2.5 x 105 freshly prepared kidney cells in Eagle's solution with various amounts of cholera toxin. In all cases, the volume of the reaction mixture was 1 ml. At the end of the incubation period, the entire incubation mixture (cells together with medium) was extracted with 10% perchloric acid. cAMP was assayed by a radioimmunoassay according to Harper and Brooker (10) , following neutralization with potassium bicarbonate and acetylation by acetic anhydride. The bound and free ligand were separated by binding of the antibody to formaldehyde-treated Staphylococcus aureus (11). Unless otherwise specified, antisera were used at a 1:10 dilution in all inhibition assays of cholera toxin-induced cAMP. In these assays, cholera toxin (50 ng in 25 p.) was incubated with 25 ul of a 1:5 dilution of antiserum (final dilution, 1:10) for 1 hr at room temperature and then this mixture was added to 2.5 x 105 dispersed kidney cells for 3 hr at 370C.
Ligated Bleal Loop Assay. The ligated ileal loop assay was carried out according to Fujita and Finkelstein (12) with slight modifications. SPD rats (8-12 weeks old) were fasted for 24 hr and then anesthetized with ether; their abdomens were opened and the small intestine was ligated in 5-to 6-cmlong loops, starting approximately 10 cm from the duodenum. The loops were injected with 1-10 ,ug of cholera toxin previously incubated with an equal volume of undiluted antiserum at room temperature for 1 hr, and then the abdomen was closed. Food and water were withheld and the animals were sacrificed after 12 hr. Fluid accumulation per centimeter of loop was determined by measuring the length and weight of each loop. Both positive (no antiserum) and nega-
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tive (no cholera toxin) controls were included in each animal.
Statistical Analysis. Student's t test was used to determine the significance of the results.
RESULTS
The antisera investigated were prepared against six synthetic peptides derived from the B subunit of cholera toxin. These peptides included sequences 8-20 (CTP1), 30-42 (CTP2), 50-64 (CTP3), 69-85 (CTP4), 75-85 (CTP5), and 83-97 (CTP6). These antisera cross-reacted to various extents with the native B subunit of the toxin (Table 1) aid were evaluated for their effect on cholera toxin-induced adenylate cyclase activity.
Adenylate Cyclase Activity. The enzyme activity was evaluated by determining the level of cAMP production in dispersed kidney cells of chicken. Cholera toxin caused a progressive and dose-dependent increase in adenylate cyclase activity of these cells, similar to the results obtained with other cell types (13) . A time course (Fig. 1) (Fig. 2) . The isolated B subunit of cholera toxin as such, or the synthetic peptides derived from it, did not induce any production of cAMP (data not shown).
The inhibitory effect on cholera toxin-induced adenylate cyclase activity of the various antisera is shown in Fig. 3 , in comparison with the inhibition effected by antiserum against the native toxin. As illustrated, the antitoxin serum was a very efficient inhibitor, causing almost complete arrest of cAMP production. Antisera against CTP1 and CTP3, although somewhat less effective, were still good inhibitors of cholera toxin activity, as manifested by the >60% reduction in induced adenylate cyclase. However, no synergistic effect of the two antisera was observed (results not shown). It is noteworthy that the inhibition by antiserum to either peptide was maintained across a wide range of cholera toxin concentrations (25-200 ng/ml of reaction mixture). On the other hand, antisera against the other four synthetic peptides, as well as the respective preimmune sera, were not inhibitory at all.
The inhibitory effect of anti-CTP1 and anti-CTP3 is specific to cholera toxin (Table 2) . Thus, the activation of adenylate cyclase by either parathyroid hormone or isoproterenol was not hindered by any of the antisera, while the cholera toxin-induced production of cAMP was drastically reduced (P < 0.01 for anti-CTP1 and anti-CTP3). Since the antipeptide sera were produced by their respective conjugates together with tetanus toxoid as carrier, an additional controli.e., antitetanus serum-was included. As shown in Table 2 , antisera specific to the tetanus toxoid carrier protein did not affect cholera toxin-induced adenylate cyclase activity.
Neutralization of the Biological Activity. The most widely used assay for the biological activity of cholera toxin is the experimental model of ligated ileal loop (8) . Injection of cholera toxin into such loops of adult rabbit or rat leads to secretion of fluid that can be quantitated. We have previously shown that anti-CTP3 is capable of partially inhibiting the fluid secretion induced by cholera toxin. The results presented in Fig. 4 illustrate these findings and show that anti-CTP1 is also inhibitory in this assay. This inhibition correlates with the effect of these antisera on the capacity of cholera toxin to induce adenylate cyclase. In contrast, no inhibitor effect was brought about by antisera against any of the other four peptides or by normal serum.
We have demonstrated that antisera-against two synthetic peptides' derived from the sequence o~f the B subunit of cholera toxin are capable of inhibiting the biologicalI activity of the intact toxin Moeoetrei very good agreement between the results obtained in two different biological assays,-adenylate cyclase aptiva'tion and fluid secretion into Hleal loops-namnely, between the biochemical level and the end biological effect of the toxin. DISCUSSION Of the six synthetic peptides investigated in this study only two showed activity-CMP and CTP3. The amino acid sequences of these peptides are CTP1, Leu-Ala-Ala-Glu-Tyr- Antiserum   FIG. 4 . Correlation between. inribition of cholera toxin by various antisera as manifested by inhibition of fluid secretion into ligated intestinal loops (o) and inhibition of ade ylate cyclase activation (n). Inhibition of cholera toxin-induced cAMP production by the different antisera was assayed using 50 ng of cholera toxin per assay.
Results represent means ± SEM of three to five separate experiments. NRS, normal rabbit serum, a, anti-; CT, cholera toxin.
His-Asn-Thr-Gln-Ile-His-Thr-Leu; CTP3, Val-Glu-Val-ProGly-Ser-Gln-His-Ile-Asp-Ser-Gln-Lys-Lys-Ala. Antibodies against CTP3 had the strongest cross-reactivity with the intact toxin. Antibodies to CTP1, on the other hand, showed less cross-reactivity, not stronger than that of antibodies to the other synthetic peptides, such as CTP6, that did not inhibit the biological activity of cholera toxin. These findings corroborate our previous premise that cross-reactivity with a native protein is not a characteristic ofjust any peptide segment derived from it and that only peptides relevant to the function of the protein induce antibodies with neutralizing capacity.
As previously reported (7), CTP1 is the only peptide that induce antibodies cross-reactive with the A subunit of cholera toxin. It has been determined (14) that, in the cholera toxin molecule, subunit A is the moiety that activates adenylate cyclase, which, in turn, triggers the biological activity, whereas subunit B is responsible for the binding of the toxin to cell receptors. Hence, it can be assumed that anti-CTP3 exerts its effect by interaction with the B subunit and blocking its attachment to the galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)-galactosylglucosylceramide (GM1) receptor of the cell membrane. The anti-CTP1 could be effec- 81 (1984) tive either by the same mechanism or, alternatively, by binding to the A subunit and thereby interfering directly with its adenylate cyclase activity. However, the finding that simultaneous addition of the two antisera does not result in additivity of the inhibitory effect suggests that the two act via similar mechanisms.
The use of synthetic peptides for immunization aims toward the future preparation of synthetic vaccines capable of protecting against infections. In the case of cholera, several vaccines, both killed and attenuated, are available but none of them provides adequate protection against the disease. The various killed vaccines, which include the whole cell antigen preparation (15, 16) , the isolated toxoid (17) , and the B subunit, with or without the whole cell preparation (18) , suffer from relatively low efficacy. Thus, clinical trials conducted with cholera vaccines have been of only marginal success in preventing clinical disease (19) (20) (21) (22) . The live attenuated vaccines, on the other hand, cause diarrhea and other side effects (23, 24) . In this context, the safety of the synthetic materials and the low hazard in their use is a crucial consideration. The 
